Identification Of Oral Antidiabetic Drug Interactions In Polypharmacy Prescription Of Patients Diabetes Mellitus At Jember Hospital

Nanda Pradwitha Fariansiska; Shinta Mayasari

Authors

Nanda Pradwitha Fariansiska Program Studi Farmasi, Fakultas Ilmu Kesehatan, Universitas dr. Soebandi
Shinta Mayasari Program Studi Farmasi, Fakultas Ilmu Kesehatan, Universitas dr. Soebandi

Keywords:

drug interactions, antidiabetic, screening, recipe, polypharmacy

Abstract

Background: Diabetes mellitus (DM) is a metabolic disorder characterized by an increase in blood glucose due to decreased insulin secretion by pancreatic beta cells, disruption or insulin resistance. The rate of DM with comorbidities or complications is increasing, usually receiving more than three types of medication (polypharmacy). The potential for drug interactions in diabetes patients is still very common. There were 186 potential drug interactions, with 16.2% potentially causing hyperglycemia and the remainder causing hypoglycemia. This can be caused by the large number of drugs that are often used (polypharmacy or multiple drug therapy). Objective: to identify potential oral antidiabetic drug interactions in screening polypharmacy prescriptions for type 2 diabetes mellitus patients in hospitals. Method: This research was conducted at one of the Jember Regency Hospitals. This type of research is descriptive research with retrospective data collection. The research sample was 80 using the Slovin formula with random sampling technique. Data analysis is displayed in the form of frequencies and percentages which are then processed using Microsoft Excel and SPSS. Results: In this study it was found that male patients were (38.8%) and female were (61.3%). The age group is dominated by patients 51 – 60 years old (42.5%). Polypharmacy consisted of at most 5 drugs (45.0%), drug interactions occurred in 65 prescriptions (81.3%) with the severity of drug interactions being moderate, 38 potential events (47.5%), major, 6 potential events (7.5%). %), minor 21 potential events (26.3%), and no interaction as many as 15 potential events (18.8%). Conclusion: This study found that the potential interactions for oral antidiabetic drugs in polypharmacy screening were mostly moderate interactions (47.5%) with 38 potential events.

References

Fitri, D. R. S., Intiyani, R., & Miyarso, C. (2022). Gambaran Potensi Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Di Instalasi Rawat Jalan Pku Muhammadiyah Sruweng. Jurnal Farmasi Klinik Dan Sains, 2(2), 20. https://doi.org/10.26753/jfks.v2i2.940

Handayani, K., & Saibi, Y. (2019). Potensi Interaksi Obat Pada Resep Pasien Diabetes Melitus Rawat Jalan di RS X Jakarta Pusat. Pharmaceutical and Biomedical Sciences Journal (PBSJ), 1(1), 43–47. https://doi.org/10.15408/pbsj.v1i1.12853

Herdaningsih, S., Muhtadi, A., Lestari, K., & Annisa, N. (2016). Potential of Drug-Drug Interaction in Polypharmacy Prescription: Retrospective Study on a Drugstore in Bandung. Indonesian Journal of Clinical Pharmacy, 5(4), 288–292. https://doi.org/10.15416/ijcp.2016.5.4.288

Interaksi, E., Pada, O., & Nopitasari, B. L. (2023). 2762 Words Excluded from Similarity Report Crossref Posted Content database Bibliographic material Evaluasi Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Rawat Jalan Di Rumah Sakit Umum Daerah Provinsi NTB Tahun 2021.

Niza, H., Anwar, S. H. A.-Z., & Arimbi, R. (2023). Evaluasi Potensi Terjadinya Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Dengan Penggunaan Obat Antibiotik di Rumah Sakit AR Bunda Prabumulih. Jurnal Kesehatan Tambusai, 4(4), 6368–6374.

Noviyanto, F., Mintarsih, R., Chairani, F., Studi, P., Farmasi, S., Tinggi, S., Kesehatan, I., Serang, S., & Serang, J. R. (2023). Gambaran Interaksi Obat Pada Pasien Diabetes Mellitus Tipe 2 di Rumah Sakit X. Journal Syifa Sciences and Clinical Research (JSSCR), 5, 347–353.

Parman, D. H., & Nyompa, H. P. (2018). Pengetahuan Tentang Diet Diabetes Melitus Berpengaruh Terhadap Kepatuhan Klien Menjalani Diet. Journal of Borneo Holistic Health, 1(1), 127–139. https://doi.org/10.35334/borticalth.v1i1.415

Poluan, O. A., Wiyono, W. I., & Yamlean, P. V. Y. (2020). Identifikasi Potensi Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Rawat Inap Di Rumah Sakit Gunung Maria Tomohon Periode Januari – Mei 2018. Pharmacon, 9(1), 38. https://doi.org/10.35799/pha.9.2020.27408

Rahmawaty, A., & Hidayah, P. H. (2020). Hubungan Drug Related Problems (DRPs) Kategori Interaksi Obat pada Penggunaan Obat Pasien Diabetes Mellitus Tipe 2. Cendekia Journal of Pharmacy, 4(1), 80–88. https://doi.org/10.31596/cjp.v4i1.76

Rasdianah, N., & Gani, A. S. W. (2021). Interaksi Obat Pada Pasien Diabetes Melitus Tipe 2 Dengan Penyakit Penyerta Di Rumah Sakit Otanaha Kota Gorontalo. Indonesian Journal of Pharmaceutical Education, 1(1), 40–46. https://doi.org/10.37311/ijpe.v1i1.9953

Rasdianah, N., Madania, M., & Pakaya, M. (2023). Studi Interaksi Obat Pasien Diabetes Melitus Tipe 2 dengan penyakit penyerta : Studi Kasus Rumah Sakit X Gorontalo. Journal Syifa Sciences and Clinical Research, 5(1), 192–199. https://doi.org/10.37311/jsscr.v5i1.8731

Retnowati, E., Nirmala, & Lestari, D. R. (2023). Hubungan Kombinasi Diabetes dan Hipertensi Terhadap Interaksi Obat pada Pasien Rawat Jalan Puskesmas Kedung-1. In Prosiding University Research Colloquium, 458–468. https://repository.urecol.org/index.php/proceeding/article/view/2465/2426

Risal, A., Khusna, K., & Pambudi, R. S. (2021). Interaksi Obat Hipoglikemia Oral (OHO) dengan Obat Lain pada Pasien Diabetes Mellitus Tipe II berdasarkan Farmakokinetik dan Farmakodinamik di Puskesmas Sangkrah. 1st E-Proceeding SENRIABDI 2021, 1(1), 979–990.

Rofifah, Dianah, jeni. (2020). Studi Pengetahuan Pasien Tentang Penggunaan Amlodipin Tablet Di Klinik Nur Ichsan Makassar. Paper Knowledge . Toward a Media History of Documents, 5, 12–26.

Rusdi, M. S. (2020). Hipoglikemia pada pasien diabetes melitus. Journal Syifa Sciences and Clinical Research, 2(September), 83–90. http://ejurnal.ung.ac.id/index.php/jsscr,

Saibi, Y., Hasan, D., & Shaqila, V. (2018). Potensi Interaksi Obat pada Pasien Diabetes Melitus Tipe 2 di Rumah Sakit X Tangerang Selatan. Jmpf, 8(3), 100–104.

Sengaji, M., Herlina, S., & Wibisono, N. (2023). Hubungan polifarmasi dengan potensi dan tingkat keparahan interaksi obat pada resep antidiabetes mellitus. Jurnal Bio Komplementer Medicine, 10(1), 1–10.

Yosmar, R., Inanta, N. P., & Sari, Y. O. (2018). Studi Prospektif Adverse Drug Reactions (ADRS) Obat Hipoglikemik Oral Terhadap Pasien Diabetes Mellitus Tipe 2 di Suatu Rumah Sakit, Padang (A Prospective Study On Adverse Drug Reactions (Adrs) Of Oral Hypoglycemic Agents Among Type 2 Diabetes Patients in. Jurnal Sains Farmasi & Klinis , 5(3), 169–175. http://jsfk.ffarmasi.unand.ac.id

Mayasari, S., Anggitasari, W., Pebriarti, I. W., & Kesehatan, F. I. (2023). Drug rationality profile in diabetes mellitus patients under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). Jurnal Eduhealth, 14(01), 2023. http://ejournal.seaninstitute.or.id/index.php/healt

Prasetyawan et al., (2024) Manajemen Farmasi. Chapter Pelayanan Farmasi Klinik. PT Penamuda Media. Yogyakarta. https://scholar.google.com/citations?view_op=view_citation&hl=id&user=uT-Fly0AAAAJ&citation_for_view=uT-Fly0AAAAJ:bEWYMUwI8FkC